RYPLAZIM
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 10 Mar 2026)
What this means for you
Registered since 10 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87247928
- Registration number
- 5929628
- Mark type
- Stylized text
- Filed
- 25 Nov 2016
- Published for opposition
- 24 Sept 2019
- Registered
- 10 Dec 2019
- Attorney of record
- Lindsay Jones
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of conditions associated with plasminogen deficiencies
Owner
- KEDRION BIOPHARMA INC., FORT LEE, NJ, US
- ProMetic BioTherapeutics, Inc., Rockville, MD, US
- ProMetic BioTherapeutics, Inc., Rockville, MD, US
- ProMetic BioTherapeutics, Inc., Rockville, MD, US
Prosecution history
- 10 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 10 Mar 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 09 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Dec 2025 — TEAS SECTION 8 & 15 RECEIVED
- 10 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Dec 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 29 Nov 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Nov 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Nov 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Nov 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Nov 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Nov 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 24 Sept 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Sept 2019 — PUBLISHED FOR OPPOSITION